Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l

Previous research indicates that knocking out absent, small, or homeotic‐like (Ash1l) in mice, a histone 3 lysine 4 (H3K4) trimethyltransferase, can result in arthritis with more severe cartilage and bone destruction. Research has documented the essential role of Ash1l in stem cell fate decision suc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stem cells (Dayton, Ohio) Ohio), 2019-01, Vol.37 (1), p.115-127
Hauptverfasser: Yin, Bei, Yu, Fanyuan, Wang, Chenglin, Li, Boer, Liu, Mengyu, Ye, Ling
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 127
container_issue 1
container_start_page 115
container_title Stem cells (Dayton, Ohio)
container_volume 37
creator Yin, Bei
Yu, Fanyuan
Wang, Chenglin
Li, Boer
Liu, Mengyu
Ye, Ling
description Previous research indicates that knocking out absent, small, or homeotic‐like (Ash1l) in mice, a histone 3 lysine 4 (H3K4) trimethyltransferase, can result in arthritis with more severe cartilage and bone destruction. Research has documented the essential role of Ash1l in stem cell fate decision such as hematopoietic stem cells and the progenitors of keratinocytes. Following up on those insights, our research seeks to document the function of Ash1l in skeletal formation, specifically whether it controls the fate decision of mesenchymal progenitor cells. Our findings indicate that in osteoporotic bones, Ash1l was significantly decreased, indicating a positive correlation between bone mass and the expression of Ash1l. Silencing of Ash1l that had been markedly upregulated in differentiated C3H10T1/2 (C3) cells hampered osteogenesis and chondrogenesis but promoted adipogenesis. Consistently, overexpression of an Ash1l SET domain‐containing fragment 3 rather than Ash1lΔN promoted osteogenic and chondrogenic differentiation of C3 cells and simultaneously inhibited adipogenic differentiation. This indicates that the role of Ash1l in regulating the differentiation of C3 cells is linked to its histone methyltransferase activity. Subcutaneous ex vivo transplantation experiments confirmed the role of Ash1l in the promotion of osteogenesis. Further experiments proved that Ash1l can epigenetically affect the expression of essential osteogenic and chondrogenic transcription factors. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Considering the promotional action of Ash1l on bone, it could potentially prompt new therapeutic strategy to promote osteogenesis. Stem Cells 2019;37:115–127 Ash1l can epigenetically promote the expression of essential osteogenic and chondrogenic transcription factors in C3H10T1/2 cells. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Ash1l hampered adipogenesis by enhancing H3K4me3 enrichment in promoter of Creb gene, which was reported to be a repressive gene of PPARγ.
doi_str_mv 10.1002/stem.2918
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2115279462</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2161869097</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3888-12c2bc84452918965de9dbea8f45f10cba80a9bb36e5651ef63c7c79a24ace433</originalsourceid><addsrcrecordid>eNp10DtPwzAUBWALgSivgT-ALLHAkGI7tmOPqJSHBGKgjChy3BtqlMTFTkH997i0MCAx-Q6fjo4PQseUDCkh7CL20A6ZpmoL7VHBdcbTvZ1uImUmiNYDtB_jGyGUC6V20SAnrCC8UHvoZTx3r9BB7ywe-a4PvsG-xg8QobOzZWsa_JTS8QiaBl-bHvAVWBed7_CHM_jWxd53kHw_WzZ9MF2sIZgI-DLOaHOIdmrTRDjavAfo-Xo8Gd1m9483d6PL-8zmSqmMMssqqzgXq09oKaagpxUYVXNRU2Iro4jRVZVLEFJQqGVuC1tow7ixwPP8AJ2tc-fBvy8g9mXrok2VTQd-EUtGqWCF5pIlevqHvvlF6FK7pCRVUhNdJHW-Vjb4GAPU5Ty41oRlSUm52rxcbV6u6iZ7sklcVC1Mf-XPyAlcrMGna2D5f1L5NBk_fEd-AQcBi2E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2161869097</pqid></control><display><type>article</type><title>Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Yin, Bei ; Yu, Fanyuan ; Wang, Chenglin ; Li, Boer ; Liu, Mengyu ; Ye, Ling</creator><creatorcontrib>Yin, Bei ; Yu, Fanyuan ; Wang, Chenglin ; Li, Boer ; Liu, Mengyu ; Ye, Ling</creatorcontrib><description>Previous research indicates that knocking out absent, small, or homeotic‐like (Ash1l) in mice, a histone 3 lysine 4 (H3K4) trimethyltransferase, can result in arthritis with more severe cartilage and bone destruction. Research has documented the essential role of Ash1l in stem cell fate decision such as hematopoietic stem cells and the progenitors of keratinocytes. Following up on those insights, our research seeks to document the function of Ash1l in skeletal formation, specifically whether it controls the fate decision of mesenchymal progenitor cells. Our findings indicate that in osteoporotic bones, Ash1l was significantly decreased, indicating a positive correlation between bone mass and the expression of Ash1l. Silencing of Ash1l that had been markedly upregulated in differentiated C3H10T1/2 (C3) cells hampered osteogenesis and chondrogenesis but promoted adipogenesis. Consistently, overexpression of an Ash1l SET domain‐containing fragment 3 rather than Ash1lΔN promoted osteogenic and chondrogenic differentiation of C3 cells and simultaneously inhibited adipogenic differentiation. This indicates that the role of Ash1l in regulating the differentiation of C3 cells is linked to its histone methyltransferase activity. Subcutaneous ex vivo transplantation experiments confirmed the role of Ash1l in the promotion of osteogenesis. Further experiments proved that Ash1l can epigenetically affect the expression of essential osteogenic and chondrogenic transcription factors. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Considering the promotional action of Ash1l on bone, it could potentially prompt new therapeutic strategy to promote osteogenesis. Stem Cells 2019;37:115–127 Ash1l can epigenetically promote the expression of essential osteogenic and chondrogenic transcription factors in C3H10T1/2 cells. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Ash1l hampered adipogenesis by enhancing H3K4me3 enrichment in promoter of Creb gene, which was reported to be a repressive gene of PPARγ.</description><identifier>ISSN: 1066-5099</identifier><identifier>EISSN: 1549-4918</identifier><identifier>DOI: 10.1002/stem.2918</identifier><identifier>PMID: 30270478</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Adipogenesis ; Animals ; Arthritis ; Biocompatibility ; Biomedical materials ; Bone mass ; Bones ; Cartilage ; Cell Differentiation ; Cell fate ; Cells (biology) ; Chondrogenesis ; Differentiation ; DNA-Binding Proteins - genetics ; DNA-Binding Proteins - metabolism ; Epigenesis, Genetic - genetics ; Epigenetics ; Hematopoietic stem cells ; Histone methyltransferase ; Histone Methyltransferases - genetics ; Histone-Lysine N-Methyltransferase - genetics ; Histone-Lysine N-Methyltransferase - metabolism ; Humans ; Keratinocytes ; Lysine ; Mesenchymal stem cells ; Mesenchymal stem cells (MSCs) ; Mesenchymal Stem Cells - metabolism ; Mesenchyme ; Mice ; Osteogenesis ; Osteoporosis ; Progenitor cells ; Stem cell transplantation ; Stem cells ; Transcription factors ; Transfection ; Transplantation</subject><ispartof>Stem cells (Dayton, Ohio), 2019-01, Vol.37 (1), p.115-127</ispartof><rights>AlphaMed Press 2018</rights><rights>AlphaMed Press 2018.</rights><rights>2019 AlphaMed Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3888-12c2bc84452918965de9dbea8f45f10cba80a9bb36e5651ef63c7c79a24ace433</citedby><cites>FETCH-LOGICAL-c3888-12c2bc84452918965de9dbea8f45f10cba80a9bb36e5651ef63c7c79a24ace433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30270478$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yin, Bei</creatorcontrib><creatorcontrib>Yu, Fanyuan</creatorcontrib><creatorcontrib>Wang, Chenglin</creatorcontrib><creatorcontrib>Li, Boer</creatorcontrib><creatorcontrib>Liu, Mengyu</creatorcontrib><creatorcontrib>Ye, Ling</creatorcontrib><title>Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l</title><title>Stem cells (Dayton, Ohio)</title><addtitle>Stem Cells</addtitle><description>Previous research indicates that knocking out absent, small, or homeotic‐like (Ash1l) in mice, a histone 3 lysine 4 (H3K4) trimethyltransferase, can result in arthritis with more severe cartilage and bone destruction. Research has documented the essential role of Ash1l in stem cell fate decision such as hematopoietic stem cells and the progenitors of keratinocytes. Following up on those insights, our research seeks to document the function of Ash1l in skeletal formation, specifically whether it controls the fate decision of mesenchymal progenitor cells. Our findings indicate that in osteoporotic bones, Ash1l was significantly decreased, indicating a positive correlation between bone mass and the expression of Ash1l. Silencing of Ash1l that had been markedly upregulated in differentiated C3H10T1/2 (C3) cells hampered osteogenesis and chondrogenesis but promoted adipogenesis. Consistently, overexpression of an Ash1l SET domain‐containing fragment 3 rather than Ash1lΔN promoted osteogenic and chondrogenic differentiation of C3 cells and simultaneously inhibited adipogenic differentiation. This indicates that the role of Ash1l in regulating the differentiation of C3 cells is linked to its histone methyltransferase activity. Subcutaneous ex vivo transplantation experiments confirmed the role of Ash1l in the promotion of osteogenesis. Further experiments proved that Ash1l can epigenetically affect the expression of essential osteogenic and chondrogenic transcription factors. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Considering the promotional action of Ash1l on bone, it could potentially prompt new therapeutic strategy to promote osteogenesis. Stem Cells 2019;37:115–127 Ash1l can epigenetically promote the expression of essential osteogenic and chondrogenic transcription factors in C3H10T1/2 cells. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Ash1l hampered adipogenesis by enhancing H3K4me3 enrichment in promoter of Creb gene, which was reported to be a repressive gene of PPARγ.</description><subject>Adipogenesis</subject><subject>Animals</subject><subject>Arthritis</subject><subject>Biocompatibility</subject><subject>Biomedical materials</subject><subject>Bone mass</subject><subject>Bones</subject><subject>Cartilage</subject><subject>Cell Differentiation</subject><subject>Cell fate</subject><subject>Cells (biology)</subject><subject>Chondrogenesis</subject><subject>Differentiation</subject><subject>DNA-Binding Proteins - genetics</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Epigenesis, Genetic - genetics</subject><subject>Epigenetics</subject><subject>Hematopoietic stem cells</subject><subject>Histone methyltransferase</subject><subject>Histone Methyltransferases - genetics</subject><subject>Histone-Lysine N-Methyltransferase - genetics</subject><subject>Histone-Lysine N-Methyltransferase - metabolism</subject><subject>Humans</subject><subject>Keratinocytes</subject><subject>Lysine</subject><subject>Mesenchymal stem cells</subject><subject>Mesenchymal stem cells (MSCs)</subject><subject>Mesenchymal Stem Cells - metabolism</subject><subject>Mesenchyme</subject><subject>Mice</subject><subject>Osteogenesis</subject><subject>Osteoporosis</subject><subject>Progenitor cells</subject><subject>Stem cell transplantation</subject><subject>Stem cells</subject><subject>Transcription factors</subject><subject>Transfection</subject><subject>Transplantation</subject><issn>1066-5099</issn><issn>1549-4918</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10DtPwzAUBWALgSivgT-ALLHAkGI7tmOPqJSHBGKgjChy3BtqlMTFTkH997i0MCAx-Q6fjo4PQseUDCkh7CL20A6ZpmoL7VHBdcbTvZ1uImUmiNYDtB_jGyGUC6V20SAnrCC8UHvoZTx3r9BB7ywe-a4PvsG-xg8QobOzZWsa_JTS8QiaBl-bHvAVWBed7_CHM_jWxd53kHw_WzZ9MF2sIZgI-DLOaHOIdmrTRDjavAfo-Xo8Gd1m9483d6PL-8zmSqmMMssqqzgXq09oKaagpxUYVXNRU2Iro4jRVZVLEFJQqGVuC1tow7ixwPP8AJ2tc-fBvy8g9mXrok2VTQd-EUtGqWCF5pIlevqHvvlF6FK7pCRVUhNdJHW-Vjb4GAPU5Ty41oRlSUm52rxcbV6u6iZ7sklcVC1Mf-XPyAlcrMGna2D5f1L5NBk_fEd-AQcBi2E</recordid><startdate>201901</startdate><enddate>201901</enddate><creator>Yin, Bei</creator><creator>Yu, Fanyuan</creator><creator>Wang, Chenglin</creator><creator>Li, Boer</creator><creator>Liu, Mengyu</creator><creator>Ye, Ling</creator><general>John Wiley &amp; Sons, Inc</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201901</creationdate><title>Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l</title><author>Yin, Bei ; Yu, Fanyuan ; Wang, Chenglin ; Li, Boer ; Liu, Mengyu ; Ye, Ling</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3888-12c2bc84452918965de9dbea8f45f10cba80a9bb36e5651ef63c7c79a24ace433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adipogenesis</topic><topic>Animals</topic><topic>Arthritis</topic><topic>Biocompatibility</topic><topic>Biomedical materials</topic><topic>Bone mass</topic><topic>Bones</topic><topic>Cartilage</topic><topic>Cell Differentiation</topic><topic>Cell fate</topic><topic>Cells (biology)</topic><topic>Chondrogenesis</topic><topic>Differentiation</topic><topic>DNA-Binding Proteins - genetics</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Epigenesis, Genetic - genetics</topic><topic>Epigenetics</topic><topic>Hematopoietic stem cells</topic><topic>Histone methyltransferase</topic><topic>Histone Methyltransferases - genetics</topic><topic>Histone-Lysine N-Methyltransferase - genetics</topic><topic>Histone-Lysine N-Methyltransferase - metabolism</topic><topic>Humans</topic><topic>Keratinocytes</topic><topic>Lysine</topic><topic>Mesenchymal stem cells</topic><topic>Mesenchymal stem cells (MSCs)</topic><topic>Mesenchymal Stem Cells - metabolism</topic><topic>Mesenchyme</topic><topic>Mice</topic><topic>Osteogenesis</topic><topic>Osteoporosis</topic><topic>Progenitor cells</topic><topic>Stem cell transplantation</topic><topic>Stem cells</topic><topic>Transcription factors</topic><topic>Transfection</topic><topic>Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yin, Bei</creatorcontrib><creatorcontrib>Yu, Fanyuan</creatorcontrib><creatorcontrib>Wang, Chenglin</creatorcontrib><creatorcontrib>Li, Boer</creatorcontrib><creatorcontrib>Liu, Mengyu</creatorcontrib><creatorcontrib>Ye, Ling</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Stem cells (Dayton, Ohio)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yin, Bei</au><au>Yu, Fanyuan</au><au>Wang, Chenglin</au><au>Li, Boer</au><au>Liu, Mengyu</au><au>Ye, Ling</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l</atitle><jtitle>Stem cells (Dayton, Ohio)</jtitle><addtitle>Stem Cells</addtitle><date>2019-01</date><risdate>2019</risdate><volume>37</volume><issue>1</issue><spage>115</spage><epage>127</epage><pages>115-127</pages><issn>1066-5099</issn><eissn>1549-4918</eissn><abstract>Previous research indicates that knocking out absent, small, or homeotic‐like (Ash1l) in mice, a histone 3 lysine 4 (H3K4) trimethyltransferase, can result in arthritis with more severe cartilage and bone destruction. Research has documented the essential role of Ash1l in stem cell fate decision such as hematopoietic stem cells and the progenitors of keratinocytes. Following up on those insights, our research seeks to document the function of Ash1l in skeletal formation, specifically whether it controls the fate decision of mesenchymal progenitor cells. Our findings indicate that in osteoporotic bones, Ash1l was significantly decreased, indicating a positive correlation between bone mass and the expression of Ash1l. Silencing of Ash1l that had been markedly upregulated in differentiated C3H10T1/2 (C3) cells hampered osteogenesis and chondrogenesis but promoted adipogenesis. Consistently, overexpression of an Ash1l SET domain‐containing fragment 3 rather than Ash1lΔN promoted osteogenic and chondrogenic differentiation of C3 cells and simultaneously inhibited adipogenic differentiation. This indicates that the role of Ash1l in regulating the differentiation of C3 cells is linked to its histone methyltransferase activity. Subcutaneous ex vivo transplantation experiments confirmed the role of Ash1l in the promotion of osteogenesis. Further experiments proved that Ash1l can epigenetically affect the expression of essential osteogenic and chondrogenic transcription factors. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Considering the promotional action of Ash1l on bone, it could potentially prompt new therapeutic strategy to promote osteogenesis. Stem Cells 2019;37:115–127 Ash1l can epigenetically promote the expression of essential osteogenic and chondrogenic transcription factors in C3H10T1/2 cells. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Ash1l hampered adipogenesis by enhancing H3K4me3 enrichment in promoter of Creb gene, which was reported to be a repressive gene of PPARγ.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>30270478</pmid><doi>10.1002/stem.2918</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1066-5099
ispartof Stem cells (Dayton, Ohio), 2019-01, Vol.37 (1), p.115-127
issn 1066-5099
1549-4918
language eng
recordid cdi_proquest_miscellaneous_2115279462
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Adipogenesis
Animals
Arthritis
Biocompatibility
Biomedical materials
Bone mass
Bones
Cartilage
Cell Differentiation
Cell fate
Cells (biology)
Chondrogenesis
Differentiation
DNA-Binding Proteins - genetics
DNA-Binding Proteins - metabolism
Epigenesis, Genetic - genetics
Epigenetics
Hematopoietic stem cells
Histone methyltransferase
Histone Methyltransferases - genetics
Histone-Lysine N-Methyltransferase - genetics
Histone-Lysine N-Methyltransferase - metabolism
Humans
Keratinocytes
Lysine
Mesenchymal stem cells
Mesenchymal stem cells (MSCs)
Mesenchymal Stem Cells - metabolism
Mesenchyme
Mice
Osteogenesis
Osteoporosis
Progenitor cells
Stem cell transplantation
Stem cells
Transcription factors
Transfection
Transplantation
title Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T13%3A57%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epigenetic%20Control%20of%20Mesenchymal%20Stem%20Cell%20Fate%20Decision%20via%20Histone%20Methyltransferase%20Ash1l&rft.jtitle=Stem%20cells%20(Dayton,%20Ohio)&rft.au=Yin,%20Bei&rft.date=2019-01&rft.volume=37&rft.issue=1&rft.spage=115&rft.epage=127&rft.pages=115-127&rft.issn=1066-5099&rft.eissn=1549-4918&rft_id=info:doi/10.1002/stem.2918&rft_dat=%3Cproquest_cross%3E2161869097%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2161869097&rft_id=info:pmid/30270478&rfr_iscdi=true